Ingalls & Snyder’s OS Therapies Inc OSTX Stock Holding History
Bought
Maintained
Sold
Other funds holding OSTX
Ingalls & Snyder's OSTX Position: Q3 2026 in Review
Ingalls & Snyder held its OS Therapies Inc (OSTX) position steady in Q3 2026 at 36,676 shares worth $59K. The position accounts for ﹤0.01% of the portfolio, ranked #466.
Ingalls & Snyder first reported a position in OSTX in Q1 2025 and has held it in 7 quarters since. The position peaked at $72K in Q3 2025. 25 funds tracked by Wall St. Rank hold OSTX as of Q3 2026.
- Ingalls & Snyder held 36,676 shares of OS Therapies Inc worth $59K as of Q3 2026.
- Ingalls & Snyder left its OS Therapies Inc share count unchanged in Q3 2026.
- OS Therapies Inc made up ﹤0.01% of Ingalls & Snyder's portfolio in Q3 2026, its #466 holding.
- Ingalls & Snyder first reported a position in OS Therapies Inc in Q1 2025 and has held it in 7 quarters since.
- Ingalls & Snyder's OS Therapies Inc position peaked at $72K in Q3 2025.
- 25 funds tracked by Wall St. Rank held OS Therapies Inc as of Q3 2026.
Based on Ingalls & Snyder's 13F filing for Q3 2026, filed 12 Nov 2026.